Zosano Pharma Corporation (NASDAQ:ZSAN) Shorts Reduced By 5.2%

Zosano Pharma Corporation (NASDAQ:ZSAN) noted a decrease of 5.2% in shorted shares. FINRA issued shorted shares of ZSAN’s total 1.64M shares. The 1.73M previous shares are down with 5.2%. Zosano Pharma Corporation (NASDAQ:ZSAN) has 88,800 shares average volume. It’ll cost 19 days for ZSAN to recover its former position. Float short on Zosano Pharma Corporation is 19.38%.

Ticker’s shares touched $3.75 during the last trading session after 0.27% change.Currently Zosano Pharma Corporation is downtrending after 77.66% change in last December 8, 2017. ZSAN has also 13,701 shares volume. ZSAN underperformed the S&P 500 by 93.28%.

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients.The firm is worth $44.90 million. The Company’s lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine.Currently it has negative earnings.

For more Zosano Pharma Corporation (NASDAQ:ZSAN) news released recently go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Globenewswire.com. The titles are as follows: “Zosano Pharma appoints new CFO – Seeking Alpha” released on October 16, 2018, “Zosano Pharma: There Is More Upside Despite Recent Run-Up – Seeking Alpha” on February 28, 2017, “Key events next week – healthcare – Seeking Alpha” with a publish date: October 19, 2018, “The Outlook For Zosano Pharma – Seeking Alpha” and the last “Zosano Reaches Another Enrollment Milestone in M207-ADAM Long-term Safety Study – GlobeNewswire” with publication date: May 14, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.